Return to homepagePandemic Pact

Evaluation of Cytosponge testing for urgent suspected cancer referrals during COVID-19 related suspension of endoscopy services

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-225

Grant search

Key facts

  • Disease

    Unspecified

  • Start & end year

    N/A

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Prof. Rebecca Fitzgerald

  • Research Location

    United Kingdom

  • Lead Research Institution

    MRC Cancer Unit

  • Research Priority Alignment

    N/A

  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Other

  • Occupations of Interest

    Unspecified

Abstract

Upper GI endoscopy services are severely limited in view of the risks of aerosol spread of coronavirus. This risks a delay in cancer diagnosis and a back-log of endoscopy referrals to facilitate once services resume. We have fast-tracked the Cytosponge technology developed in Cambridge to provide a triage service for 2WW referrals.